Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

April 22, 2021

Study Completion Date

August 26, 2021

Conditions
Osteoarthritis
Interventions
DRUG

LY3016859

LY3016859 given IV.

DRUG

Placebo

Placebo given IV.

Trial Locations (33)

16635

Altoona Center For Clinical Research, Duncansville

19610

Clinical Research Center of Reading,LLC, Wyomissing

27408

PharmQuest, Greensboro

29405

Coastal Carolina Research Center, North Charleston

32162

Synexus Clinical Research US, Inc - Orlando, The Villages

32806

Synexus - US, Orlando

33135

Suncoast Research Group, Miami

33317

Gold Coast Research, Plantation

33781

Synexus - US, Pinellas Park

34470

Renstar Medical Research, Ocala

35211

Simon Williamson Clinic, Birmingham

43213

Aventiv Research Inc, Columbus

44122

Rapid Medical Research, Cleveland

45236

Synexus - Cincinnati, Cincinnati

48706

Great Lakes Research Group, Inc., Bay City

60602

Synexus Clinical Research, Chicago

60611

Northwestern University, Chicago

63303

StudyMetrix Research, City of Saint Peters

66606

Cotton O'Neil Infusion Center, Topeka

68144

Synexus - US, Omaha

75234

Synexus - US, Dallas

78229

Synexus - US, San Antonio

84123

Synexus - US, Murray

85224

Synexus- Chandler, Chandler

85306

Synexus Clinical Research - Glendale, Glendale

92103

Artemis Institute for Clinical Research, San Diego

92503

Artemis Institute for Clinical Research, Riverside

92614

Irvine Clinical Research Center, Irvine

98057

Rainier Clinical Research Center, Renton

01844

ActivMed Practices and Research, Methuen

02451

MedVadis Research Corporation, Waltham

98007-4209

Northwest Clinical Research Center, Bellevue

00909

Latin Clinical Trial Center, San Juan

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04456686 - Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis | Biotech Hunter | Biotech Hunter